Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Qualigen Therapeutics ( (QLGN) ) has issued an update.
Graydon Bensler has been appointed as an independent board member, bringing over seven years of financial consulting and management experience. A Chartered Financial Analyst, Bensler co-founded an Ed Tech company and held key roles in investor relations and investment banking. His expertise in capital markets and public company compliance is expected to benefit the board significantly.
See more data about QLGN stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money